The melanoma burden in Belgium; premature morbidity and mortality make melanoma a considerable health problem

Melanoma Research

Volumn 9, Issue 6, 1999, Pages 614-618

  Brochez, L ^a,b   Myny, K ^b   Bleyen, L ^b   De Backer, G ^b   Naeyaert, J M ^b  

^a RESEARCH FOUNDATION FLANDERS FWO   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Melanoma; Premature morbidity; Premature mortality; Years of potential life lost

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BELGIUM; CANCER INCIDENCE; CANCER MORTALITY; CANCER SURVIVAL; CHILD; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MELANOMA; PRIORITY JOURNAL;

EID: 0033408369     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-199912000-00013     Document Type: Article

References (20)

1. Armstrong BK. Descriptive epidemiology of skin cancers. In: Grob JJ, Stem RS, MacKie RM, Weinstock WA, eds. Epidemiology, causes and Prevention of Skin Diseases, 1st edn. Blackwell Science, 1997: 41-47.
2. Armstrong BK, English DR. Epidemiologic studies. In: Balch CM, Houghton A, Milton G, Sober AJ, Soong S, eds. Cutaneous Melanoma, 2nd edn. Philadelphia, JB Lippincott, 1992: 12-26.
3. Österlind A. Epidemiology on malignant melanoma in Europe. Acta Oncol 1992; 31: 903-908.
4. Grin-Jorgensen C, Rigel DS, Friedman RJ. The worldwide incidence of malignant melanoma. In: Balch CM, Houghton A, Milton G, Sober AJ, Soong S, eds. Cutaneous Melanoma, 2nd edn. Philadelphia, JB Lippincott, 1992: 27-39.
5. Armstrong BK, Kricker A. Cutaneous melanoma. Cancer Surv 1994; 19: 219-240.
6. Gloster HM, Brodland DG. The epidemiology of skin cancer. Dermatol Surg 1996; 22: 217-226.
7. Haelterman M, ed. Kanker in België 1987-89. Belgisch werk tegen Kanker-Ministerie van Sociale Zaken, Volksgezondheid en Leefmilieu, 1991.
8. Haelterman M, ed. Kanker in België 1990-1992. Belgisch werk tegen Kanker-Ministerie van Sociale Zaken, Volksgezondheid en Leefmilieu, 1994.
9. Statistiek van de doodsoorzaken, numbers 12 (1987), 13 (1988), 14 (1989), 15 (1990), 16 (1991) and 17 (1992). Nationaal Instituut voor de Statistiek-Ministerie van Economische Zaken, Koninkrijk België.
10. Bevolkingsstatistieken 1987, 1988, 1989, 1990, 1991 and 1992. Nationaal Instituut voor de Statistiek-Ministerie van Economische Zaken, Koninkrijk België.
11. Breslow NE, Day NE. Statistical Methods in Cancer Research - Vol II: The Design and Analysis of Cohort Studies. IARC Scientific Publications No. 82. Lyon: IARC, 1987.
12. Romeder JM, McWhinnie JR. Potential years of life lost between ages 1 and 70: an indicator of premature mortality for health planning. Int J Epidemiol 1977; 6: 143-151.
13. Albert VA, et al. Years of potential life lost: another indicator of the impact of cutaneous malignant melanoma on society. J Am Acad Dermatol 1990; 23: 308-310.
14. Vossaert KA, et al. Influence of gender on survival in patients with stage I malignant melanoma. J Am Acad Dermatol 1992; 26:429-440.
15. Rigel DS, Friedman RJ, Kopf AW. The incidence of malignant melanoma in the United States: issues as we approach the 21st century. J Am Acad Dermatol 1996; 34: 839-847.
16. De Henauw S, de Smet P, Aelvoet W, De Backer G. Misclassification of coronary heart disease in mortality statistics. Evidence from the WHO-MONICA Ghent-Charleroi Study in Belgium. J Epidemiol Community Health 1998; 52: 513-519.
17. Roush GC, McKay L, Holford TR. A reversal in the long-term increase in deaths attributable to malignant melanoma. Cancer 1992; 69: 1714-1720.
18. Koh HK, et al. Underreporting of cutaneous melanoma in cancer registries nationwide. J Am Acad Dermatol 1992; 6: 1035.
19. Melia J, et al. Problems with registration of cutaneous malignant melanoma in England. Br J Cancer 1995; 72: 224-228.
20. Brochez L, et al. Underregistration of melanoma in Belgium: an analysis. Melanoma Res 1999; 9: 413-18.